凉血解毒、滋肾柔肝法治疗慢性肝炎肝纤维化40例临床观察

刘敏; 李献平; 陈增潭

doi:10.13288/j.11-2166/r.2004.10.021

您当前的位置：

首页 >

文章列表页 >

凉血解毒、滋肾柔肝法治疗慢性肝炎肝纤维化40例临床观察

更新时间：2021-11-22

- 凉血解毒、滋肾柔肝法治疗慢性肝炎肝纤维化40例临床观察
- Clinical Observation on Removing Pathogenic Heat from the Blood and Toxic Material from the Body and Nourishing the Kidney and Liver Method for Treatment of 40 Cases of Fibrosis of Liver due to Chronic Hepatitis
- 中医杂志 2004年第10期页码：750-751
- 作者机构：
  
  1. 北京中医医院肝病科
  2. 北京中医药大学继续教育学院
  3. 北京中医医院肝病科北京市东城区美术馆后街23号,100010
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2004.10.021
  中图分类号： R259.7
- 纸质出版：2004
- 稿件说明：
移动端阅览
[1]刘敏,李献平,陈增潭.凉血解毒、滋肾柔肝法治疗慢性肝炎肝纤维化40例临床观察[J].中医杂志,2004(10):750-751.

Liu Min~1, Li Xianping~2, Chen Zengtan~1. Clinical Observation on Removing Pathogenic Heat from the Blood and Toxic Material from the Body and Nourishing the Kidney and Liver Method for Treatment of 40 Cases of Fibrosis of Liver due to Chronic Hepatitis[J]. Journal of Traditional Chinese Medicine2004, (10): 750-751.
[1]刘敏,李献平,陈增潭.凉血解毒、滋肾柔肝法治疗慢性肝炎肝纤维化40例临床观察[J].中医杂志,2004(10):750-751. DOI： 10.13288/j.11-2166/r.2004.10.021.

Liu Min~1, Li Xianping~2, Chen Zengtan~1. Clinical Observation on Removing Pathogenic Heat from the Blood and Toxic Material from the Body and Nourishing the Kidney and Liver Method for Treatment of 40 Cases of Fibrosis of Liver due to Chronic Hepatitis[J]. Journal of Traditional Chinese Medicine2004, (10): 750-751. DOI： 10.13288/j.11-2166/r.2004.10.021.

摘要

目的:研究中药对慢性肝炎肝纤维化的治疗作用。方法:治疗组（40例）予以凉血解毒、滋肾柔肝中药治疗

对照组（30例）予以澳泰乐冲剂和大黄（庶虫）虫丸

疗程6个月

观察肝纤维化指标的变化情况。结果:治疗组病人经治疗后血清透明质酸（HA）、层粘蛋白（LM）、Ⅳ型胶原肽（C-Ⅳ）及Ⅲ型前胶原肽（PⅢP）均明显降低

与对照组比较

有显著性差异（P<0.05）。结论:凉血解毒、滋肾柔肝法是治疗慢性肝炎肝纤维化的重要法则

所选方药是临床治疗慢性肝炎肝纤维化的有效药物。

Abstract

Objective: To study therapeutic action of Chinese drugs on fibrosis of liver due to chronic hepatitis. Methods: The treatment group （n=40） were treated by Chinese drugs for removing pathogenic heat from the blood and toxic material from the body

and nourishing the kidney and liver

and the control group（n=30） were treated by Aotaile Infusing Powder and Dahuang Zhechong Bolus for 6 months. Changes of indexes of fibrosis of liver were investigated. Results: After treatment

serum hyaluronic acid （HA）

laminin（LM）

type Ⅳ collagen peptide

and type Ⅲ collagen peptide decreased in the treatment group as compared with those in the control group （P<0.05）. Conclusion: The method of removing pathogenic heat from the blood and toxic material from the body and nourishing the kidney and liver is an important law

and prescription drugs selected are clinically effective drugs for fibrosis of liver due to chronic hepatitis.

关键词

Keywords

references

查看原文

浏览量

130

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

慢性高黄疸肝炎特殊见症——头汗出124例治疗报告

康肾-868治疗慢性肾功能不全临床研究

下瘀血汤对进展期大鼠肝纤维化的抑制作用及其方证探讨

益气软肝方与肝刺激因子对大鼠免疫性肝纤维化保护作用的对照研究

扶正化瘀方促进二甲基亚硝胺肝纤维化大鼠肝窦毛细血管化逆转作用的实验研究